Tag Archive for: AAV

Katholieke Universiteit Leuvenadobe stock - aliaksandr
Partnership

eXmoor Pharma and KU Leuven join forces in AAV production

British cell and gene therapy CDMO eXmoor Pharma plc, and KU Leuven which has just launched a translational cell and gene therapy hub in Belgium have inked a strategic collaboration supporting the hub’s work in four areas.

Read more
Mechanism of action and IV devlivery of Sangamo's Tau-ZFRSangamo Therapeutics Inc
partnership

Roche inks US$2bn biobucks deal with Sangamo

After Sangamo Therapeutics Inc. presented an epigenetic ZFN-based repressor at ASGCT 2024 that reduces the expression of the tau protein in the hippocampus by 95% in Alzheimer’s models, Roche’s US subsidiary Genentech has licensed the experimental gene therapy.

Read more
Fundus of patient with teinitis pigmentosa. © By Christian Hamel - wikimedia.org
Ophthalmology

Three companies launch gene therapy alliance for eye diseases

AI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.

Read more
In future, gene vectors for novel gene therapies will be developed and produced for clinical trials on an industrial scale by around 100 employees in the new gene therapy development centre at Roche in Penzberg, which covers around 2,500 square metres. © Roche
gene therapy

Roche opens €90m gene therapy development centre

Basel-headquartered Roche AG has inaugurated a brand new €90m gene therapy development centre in Penzberg near Munich.

Read more
© Biovian Oy
CGT

Upscaling AAV gene therapy

Biovian Oy’s second generation AAV platform will include Remedium Bio Inc.’s lead treatment candidate against Osteoarthritis.

Read more